PL434553A1 - Chemical compound used as a diagnostic marker of cancer, method of its preparation, method of diagnosing epithelial cancers - Google Patents

Chemical compound used as a diagnostic marker of cancer, method of its preparation, method of diagnosing epithelial cancers

Info

Publication number
PL434553A1
PL434553A1 PL434553A PL43455318A PL434553A1 PL 434553 A1 PL434553 A1 PL 434553A1 PL 434553 A PL434553 A PL 434553A PL 43455318 A PL43455318 A PL 43455318A PL 434553 A1 PL434553 A1 PL 434553A1
Authority
PL
Poland
Prior art keywords
cancer
preparation
diagnostic marker
chemical compound
compound used
Prior art date
Application number
PL434553A
Other languages
Polish (pl)
Other versions
PL238699B1 (en
Inventor
Adam LESNER
Natalia Gruba
Original Assignee
Uniwersytet Gdański
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Gdański filed Critical Uniwersytet Gdański
Priority to PL434553A priority Critical patent/PL238699B1/en
Publication of PL434553A1 publication Critical patent/PL434553A1/en
Publication of PL238699B1 publication Critical patent/PL238699B1/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Związek o wzorze ogólnym: ABZ1-Met2-Lys3-Val4-Trp5-pNA6 gdzie: ABZ oznacza kwas 2-aminobenzoesowy, pNA oznacza 4-nitroanilinę oraz sposób otrzymywania związku. Wynalazek obejmuje marker diagnostyczny o wzorze ogólnym ABZ1-Met2-Lys3-Val4-Trp5 -pNA6 do zastosowania w diagnostyce nowotworu oraz sposób diagnozowania nowotworu nabłonkowego w materiale biologicznym ssaka z użyciem markera.A compound of the general formula: ABZ1-Met2-Lys3-Val4-Trp5-pNA6 where: ABZ is 2-aminobenzoic acid, pNA is 4-nitroaniline and a method of obtaining the compound. The invention includes a diagnostic marker of the general formula ABZ1-Met2-Lys3-Val4-Trp5 -pNA6 for use in diagnosing cancer and a method of diagnosing epithelial cancer in biological material of a mammal using the marker.

PL434553A 2018-07-14 2018-07-14 A chemical compound used as a tumor diagnostic marker, method of preparation, method of diagnosing epithelial neoplasms PL238699B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL434553A PL238699B1 (en) 2018-07-14 2018-07-14 A chemical compound used as a tumor diagnostic marker, method of preparation, method of diagnosing epithelial neoplasms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL434553A PL238699B1 (en) 2018-07-14 2018-07-14 A chemical compound used as a tumor diagnostic marker, method of preparation, method of diagnosing epithelial neoplasms

Publications (2)

Publication Number Publication Date
PL434553A1 true PL434553A1 (en) 2020-12-28
PL238699B1 PL238699B1 (en) 2021-09-27

Family

ID=78055856

Family Applications (1)

Application Number Title Priority Date Filing Date
PL434553A PL238699B1 (en) 2018-07-14 2018-07-14 A chemical compound used as a tumor diagnostic marker, method of preparation, method of diagnosing epithelial neoplasms

Country Status (1)

Country Link
PL (1) PL238699B1 (en)

Also Published As

Publication number Publication date
PL238699B1 (en) 2021-09-27

Similar Documents

Publication Publication Date Title
AR119997A1 (en) ANTI-KLK7 ANTIBODIES, ANTI-KLK5 ANTIBODIES, MULTISPECIFIC ANTI-KLK5 / KLK7 ANTIBODIES AND METHODS OF USE
UY38793A (en) CHEMICAL COMPOUNDS
MX2021006560A (en) Transcriptomic profiling for prognosis of breast cancer.
CL2024002250A1 (en) Use of anti-vd1 antibody to treat cancer, an infectious disease or an inflammatory disease.
JOP20210218A1 (en) operations and vehicles
MX2020008075A (en) Anti-ctla4 antibodies and methods of making and using the same.
MY202410A (en) Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
CO2022009737A2 (en) Anti-ly6g6d antibodies and methods of use
MX394474B (en) PROGNOSTIC METHODS FOR NON-MUSCLE-INVASIVE BLADDER CANCER AND ANTAGONISTS FOR USE IN ITS TREATMENT.
MX2021007768A (en) ANTI-CTLA4 ANTIBODIES AND METHODS OF USE THEREOF.
BR112018007296A2 (en) antibody conjugates comprising toll-like receptor agonist
ATE554389T1 (en) APEX AS A MARKER FOR LUNG CANCER
BR112016029521A2 (en) ? kit, device and method for the detection of stomach cancer?
BR112017003472A2 (en) antibodies, antibody fab fragment and method for treating an inflammatory disease
CO2019002607A2 (en) Biomarkers of metabolites for diseases associated with the contact activation system
UY36200A (en) SET OF SPECIFIC BIOMARKERS FOR NON-INVASIVE DIAGNOSIS OF LIVER CANCER
CR10143A (en) ANTIGENS OF DES-N-ACETYL-SIALIC ACID, ANTIBODIES FOR THE SAME AND METHODS OF USE IN CANCER THERAPY
BR112022012731A2 (en) ANTI-OX40 ANTIBODY AND USE OF IT
BR112013021056A2 (en) monoclonal antibody, hybridoma cell line, diagnostic kit, methods for producing a monoclonal antibody and binding agent, purified amino acid sequence binding agent, method for obtaining a coding nucleic acid sequence, antibody molecule encoding isolated nucleic acid, vector, isolated host cell, fusion protein, screening method for the presence of a disease, a condition, methods of diagnosing an individual, prognosis for an individual, and monitoring an individual, and , method for detecting the presence or absence of cervical cancer
BR112018073348B8 (en) METHODS FOR PREPARING 6-ARYL-4-AMINOPICOLINATES AND 2-ARYL-6-AMINOPYRIMIDINE-4-CARBOXYLATES BY SUZUKI DIRECT COUPLING
BR112019020412A2 (en) compositions and methods to detect lung cancer
ATE545867T1 (en) I-PLASTIN TEST METHOD FOR IN VITRO DIAGNOSIS OF COLORECTAL CARCINOMA
MX2022002886A (en) RADIOLABELED MET UNION PROTEINS FOR IMAGING BY IMMUNO-PET.
PL434553A1 (en) Chemical compound used as a diagnostic marker of cancer, method of its preparation, method of diagnosing epithelial cancers
PL408905A1 (en) New compound, method for obtaining it, pharmaceutical solution containing the new compound, method for determination of the presence of tumor disease, accessories for cancer detection and application of the hydrolysis of the new compound for cancer detection